Following completion of antiplatelet monotherapy (i.e., Plavix) plus oral anticoagulation in patients with AFib post-PCI, would you favor continuing antiplatelet therapy + OAC, switching from Plavix to aspirin and continuing OAC, or stopping antiplatelet therapy and continuing OAC?

Answer from: at Community Practice

My practice has always been to continue ASA in addition to anticoagulation but I'm starting to change this practice and remove antiplatelet therapy and continue OAC alone, especially in higher bleeding risk patients. There have been a couple of studies (AFIRE and OAC-ALONE) that would seem to suppor...

Comments

at Heart And Sleep Clinics Of America
It raised interesting questions. How long to use ...

at Lawrence Park Radiology
Aspirin is ineffective based on the failure of asp...

Answer from: at Academic Institution

To avoid confusion with different styles within our system, we have adopted a standard practice in our lab to use triple therapy for 1 week. Then after 1 week, we drop ASA. We tend to prefer ASA, clopidogrel + OAC. But if they could not take clopidogrel (for any reason) then we still use the same pr...

Answer from: at Community Practice

The current ACC guidelines recommend stopping anti-platelet agent after one year and continuing DOACs.

Comments

at Kaiser Permanente Panorama City Medical Center
After 1 year, I prefer to continue OAC and Plavix.

Please select the option that best describes you:

Following completion of antiplatelet monotherapy (i.e., Plavix) plus oral anticoagulation in patients with AFib post-PCI, would you favor continuing antiplatelet therapy + OAC, switching from Plavix to aspirin and continuing OAC, or stopping antiplatelet therapy and continuing OAC?

Related Questions